BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6338440)

  • 1. Oral lesions in borderline and reactional tuberculoid leprosy.
    Alfieri N; Fleury RN; Opromolla DV; Ura S; de Campos I
    Oral Surg Oral Med Oral Pathol; 1983 Jan; 55(1):52-7. PubMed ID: 6338440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oral mucosa in paucibacillary leprosy: a clinical and histopathological study.
    de Abreu MA; Alchorne MM; Michalany NS; Weckx LL; Pimentel DR; Hirata CH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):e48-52. PubMed ID: 17223587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Mitsuda tests for identification of reactional tuberculoid and reactional borderline leprosy forms.
    Lastoria LC; Opromolla DV; Fleury RN; Habermann F; Curi PR
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):190-200. PubMed ID: 9728451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of changes in the nasal mucosa in indeterminate, tuberculoid and borderline leprosy.
    Chacko CJ; Bhanu T; Victor V; Alexander R; Taylor PM; Job CK
    Lepr India; 1979 Jan; 51(1):8-22. PubMed ID: 376945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T regulatory cells (TREG)(TCD4+CD25+FOXP3+) distribution in the different clinical forms of leprosy and reactional states.
    Parente JN; Talhari C; Schettini AP; Massone C
    An Bras Dermatol; 2015; 90(1):41-7. PubMed ID: 25672298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium leprae in the striated muscle of tuberculoid leprosy patients.
    Koranne RV; Singh R; Iyengar B
    Lepr India; 1978 Jul; 50(3):375-80. PubMed ID: 359926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral lesion in leprosy: borderline tuberculoid diagnosis based on detection of Mycobacterium leprae DNA by qPCR.
    da Silva Martinez T; Nahas AA; Figueira MM; Costa AV; Gonçalves MA; Goulart LR; Goulart IM
    Acta Derm Venereol; 2011 Oct; 91(6):704-7. PubMed ID: 21879249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oral cavity in leprosy: what clinicians need to know.
    Rodrigues GA; Qualio NP; de Macedo LD; Innocentini L; Ribeiro-Silva A; Foss NT; Frade M; Motta A
    Oral Dis; 2017 Sep; 23(6):749-756. PubMed ID: 27606832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic changes in the soft palate in lepromatous leprosy. An evaluation of ten patients.
    Reichart P
    Oral Surg Oral Med Oral Pathol; 1974 Dec; 38(6):898-904. PubMed ID: 4614162
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating cytokine profiles in leprosy patients.
    Belgaumkar VA; Gokhale NR; Mahajan PM; Bharadwaj R; Pandit DP; Deshpande S
    Lepr Rev; 2007 Sep; 78(3):223-30. PubMed ID: 18035773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.
    Bjune G; Barnetson RS; Ridley DS; Kronvall G
    Clin Exp Immunol; 1976 Jul; 25(1):85-94. PubMed ID: 791549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral mucosa in leprosy: a clinical and histopathological study.
    de Abreu MA; Michalany NS; Weckx LL; Neto Pimentel DR; Hirata CH; de Avelar Alchorne MM
    Braz J Otorhinolaryngol; 2006; 72(3):312-6. PubMed ID: 17119765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
    Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
    Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral mucosa as a source of Mycobacterium leprae infection and transmission, and implications of bacterial DNA detection and the immunological status.
    Martinez TS; Figueira MM; Costa AV; Gonçalves MA; Goulart LR; Goulart IM
    Clin Microbiol Infect; 2011 Nov; 17(11):1653-8. PubMed ID: 21199152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional lymph node involvement in tuberculoid leprosy.
    Apte DC; Zawar M; Mehta MC; Zawar PB; Chawhan RN
    Lepr India; 1983 Oct; 55(4):680-5. PubMed ID: 6668925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell heterogeneity and anti-inflammatory annexin A1 expression in leprosy skin lesions.
    Costa MB; Mimura KKO; Freitas AA; Hungria EM; Sousa ALOM; Oliani SM; Stefani MMA
    Microb Pathog; 2018 May; 118():277-284. PubMed ID: 29605649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of polymerase chain reaction in the diagnosis of early leprosy.
    Job CK; Jayakumar J; Williams DL; Gillis TP
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):461-4. PubMed ID: 9465155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micropathological changes in the sub-epidermal zone of normal appearing skin in leprosy.
    Rastogi R; Budhiraja V; Babu CS; Madan M; Krishna A; Asthana AK
    Rom J Morphol Embryol; 2011; 52(1):165-9. PubMed ID: 21424049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.